The present invention provides an in vitro method for determining the prognosis in a patient suffering a heart failure disease, the method comprising the step of determining the level of soluble neprilysin (NEP) in a test sample of the patient.
申请公布号
EP2990800(A1)
申请公布日期
2016.03.02
申请号
EP20140182846
申请日期
2014.08.29
申请人
FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL
